Meanwhile, following treatment with FFDZ, the changes in HOMA-IR in the NAFLD mice exhibited a trend like that of serum insulin and glucose levels, as shown in Figure 3O. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.